Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer

Trial Details

NCT ID
NCT06026943
Phase
NA
Sponsor
Alpha Tau Medical LTD.
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • DaRT seeds insertion
Locations (sample)
  • Verona, Italy|45.43854,10.9938

Key Eligibility Criteria

  • Histologically and/or cytologically proven NCCN locally advanced PC
  • Patients must have i) received at least one line of chemotherapy (any kind) OR ii) are medically unfit for further chemotherapy, AND iii) the tumor…
  • DaRT indication validated by a multidisciplinary team.
  • Measurable lesion per RECIST (version 1.1) criteria

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →